ES2456267T3 - Medicamento con levadura - Google Patents

Medicamento con levadura Download PDF

Info

Publication number
ES2456267T3
ES2456267T3 ES08841666.4T ES08841666T ES2456267T3 ES 2456267 T3 ES2456267 T3 ES 2456267T3 ES 08841666 T ES08841666 T ES 08841666T ES 2456267 T3 ES2456267 T3 ES 2456267T3
Authority
ES
Spain
Prior art keywords
yeast
drug
medicament
group
medication
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08841666.4T
Other languages
English (en)
Spanish (es)
Inventor
Bodo Asmussen
Christiane Schiller
Werner Weitschies
Gregor Garbacz
Mahmoud A. Omer-Adam
Stefan Nagel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LTS Lohmann Therapie Systeme AG
Original Assignee
LTS Lohmann Therapie Systeme AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40299087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2456267(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by LTS Lohmann Therapie Systeme AG filed Critical LTS Lohmann Therapie Systeme AG
Application granted granted Critical
Publication of ES2456267T3 publication Critical patent/ES2456267T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ES08841666.4T 2007-09-01 2008-08-21 Medicamento con levadura Active ES2456267T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102007041588A DE102007041588A1 (de) 2007-09-01 2007-09-01 Arzneimittel mit Hefe
DE102007041588 2007-09-01
PCT/EP2008/006897 WO2009052888A2 (de) 2007-09-01 2008-08-21 Arzneimittel mit hefe

Publications (1)

Publication Number Publication Date
ES2456267T3 true ES2456267T3 (es) 2014-04-21

Family

ID=40299087

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08841666.4T Active ES2456267T3 (es) 2007-09-01 2008-08-21 Medicamento con levadura

Country Status (14)

Country Link
US (1) US20120027856A1 (enExample)
EP (1) EP2180885B1 (enExample)
JP (1) JP2010536903A (enExample)
KR (1) KR101259673B1 (enExample)
CN (1) CN101795676B (enExample)
AU (1) AU2008316051A1 (enExample)
CA (1) CA2698327C (enExample)
DE (1) DE102007041588A1 (enExample)
ES (1) ES2456267T3 (enExample)
MX (1) MX2010002167A (enExample)
NZ (1) NZ584233A (enExample)
RU (1) RU2452473C2 (enExample)
WO (1) WO2009052888A2 (enExample)
ZA (1) ZA201000853B (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009027938A1 (de) * 2009-07-22 2011-01-27 Universität Greifswald Orales therapeutisches System und seine Verwendung
EP2839377A4 (en) * 2012-04-20 2015-12-02 Enmotus Inc STORAGE SYSTEM WITH DATA MANAGEMENT MECHANISM AND METHOD FOR OPERATION THEREOF
WO2015190456A1 (ja) * 2014-06-10 2015-12-17 ライオン株式会社 清酒酵母を含有する錠剤
US11291683B2 (en) * 2016-04-01 2022-04-05 Access Business Group International Llc Bilayer tablets of B vitamins and process for preparing the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675174A (en) * 1985-08-16 1987-06-23 Alza Corporation Veterinary dispenser delivering beneficial agent by gas power generated in situ
EP0737473A1 (en) 1989-10-02 1996-10-16 Cima Labs, Inc. Effervescent dosage form
WO2000076478A1 (en) * 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
DE10120092B4 (de) * 2001-04-25 2008-03-20 Lts Lohmann Therapie-Systeme Ag Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
WO2002102415A1 (en) * 2001-06-18 2002-12-27 Blue Cross Laboratories Limited Gastric floating system
WO2003000112A2 (en) 2001-06-20 2003-01-03 The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of ribonuclease l in diagnosis of cancer
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
CA2501345A1 (en) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Gastro-retentive levodopa delivery form
US6835397B2 (en) * 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
US20060003003A1 (en) 2004-06-28 2006-01-05 Bakker Johan A Oral sustained release formulation of tedisamil with gastric retention properties
DE102004042139B4 (de) 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
WO2009008726A1 (en) * 2007-07-12 2009-01-15 Dsm Ip Assets B.V. Nitrate reduction by a probiotic in the presence of a heme

Also Published As

Publication number Publication date
DE102007041588A1 (de) 2009-03-05
MX2010002167A (es) 2010-04-29
CN101795676A (zh) 2010-08-04
KR101259673B1 (ko) 2013-05-06
WO2009052888A2 (de) 2009-04-30
WO2009052888A3 (de) 2009-10-15
NZ584233A (en) 2012-02-24
ZA201000853B (en) 2010-10-27
RU2452473C2 (ru) 2012-06-10
RU2010109523A (ru) 2011-10-20
JP2010536903A (ja) 2010-12-02
US20120027856A1 (en) 2012-02-02
CN101795676B (zh) 2012-11-28
CA2698327A1 (en) 2009-04-30
CA2698327C (en) 2013-04-30
KR20100059880A (ko) 2010-06-04
AU2008316051A1 (en) 2009-04-30
EP2180885B1 (de) 2014-01-29
EP2180885A2 (de) 2010-05-05

Similar Documents

Publication Publication Date Title
Gupta et al. Osmotically controlled drug delivery system with associated drugs
ES2163504T5 (es) Formas de dosificacion de liberacion controlada de azitromicina.
ES2739856T3 (es) Formulaciones de liberación modificada y procedimientos para el tratamiento de la enfermedad intestinal inflamatoria
KR101268215B1 (ko) 알긴산 바디를 포함하는 위장 체류 시스템
EP2143424A1 (en) Oral pharmaceutical preparation for colon-specific delivery
CA2851765C (en) A gastroretentive dosage system and process of preparation thereof
KR20060076331A (ko) 테르비나핀을 포함하는 제약학적 조성물 및 그의 용도
CN101732275A (zh) 一种单硝酸异山梨酯双层渗透泵控释片及其制备方法
CN101795676B (zh) 包含酵母的药物产品
Parmar et al. Pulsatile drug delivery systems: an overview
CN106511293A (zh) 含有达方吡啶的缓释口服制剂及其用途
EP4299056A1 (en) Sleep regulation tablet allowing release by stage and preparation method therefor
CN102764243B (zh) 一种阿司匹林脉冲释放微丸和其制剂及其制备方法
CN105055360A (zh) 一种盐酸哌唑嗪控释片及其制备方法
CN101642443A (zh) 单硝酸异山梨酯渗透泵型控释制剂及其制备方法
KR20080110876A (ko) 박동성 방출을 위한 경구용 제약 코팅 조성물
ES2335394T3 (es) Dispositivo resistenete a los jugos gastricos para la liberacion de excipientes de principios activos mucoadhesivos y procedimiento de realizacion de dicho dispositivo resistente a los jugos gastricos.
US20100143472A1 (en) Osmotic form for controlled release of active principles
CN112294777B (zh) 一种盐酸伊伐布雷定缓释制剂及其制备方法和应用
WO2013051036A1 (en) Use of pharmaceutical composition for gastroretentive sustained and pulsatile drug delivery system
CN101869572A (zh) 含有双胍类降糖药物和普利类降压药物的组合物及其用途
US20170172928A1 (en) Pharmaceutical system for oral delivery of sensitive therapeutic substances
HK40031748B (en) Controlled-release pharmaceutical composition and preparation method therefor
Yajaman et al. Novel drug delivery systems and regulatory affairs
HK40031748A (en) Controlled-release pharmaceutical composition and preparation method therefor